Every FDA-registered compounding facility, with its inspection record · free, no accountLook up a pharmacy →
Licensed Compounder

Home › 503B register › New Jersey

FDA register as of 2026-10-13 · Compiled and edited by

503B outsourcing facilities in New Jersey

The FDA lists 8 registered 503B outsourcing facilities in New Jersey as of 2026-10-13: 4 inspected, 4 with a Form 483, 0 with a warning letter or equivalent action. The most recent FDA inspection among them is dated 8/18/2026, at Imprimis NJOF, LLC in Ledgewood.

New Jersey's 503B facilities at a glance

Where they are
Bloomsbury, Buena, East Windsor, Hackettstown, Ledgewood, Mt. Laurel, New Providence, Somerset
Most recent FDA inspection
8/18/2026 at Imprimis NJOF, LLC, Ledgewood · action: Open
Not yet inspected
4 of 8
Registered with the FDA
Earliest: Imprimis NJOF, LLC, 11/12/2016. Newest: Hyalo Technologies Limited Liability Company, 5/1/2025.
Recall conducted
0 of 8, per the FDA's recall column
Intend to compound sterile drugs from bulk substances
8 of 8, per the FDA's column of that name

The FDA's record for each New Jersey facility

FacilityFirst registeredLast FDA inspectionForm 483RecallAction
Denver Solutions, LLC, dba Leiters Health
Buena, NJ
7/1/2022Not yet inspected——No inspection yet
Empower Clinic Services New Jersey
East Windsor, NJ
6/10/2024Not yet Inspected——No inspection yet
Hyalo Technologies Limited Liability Company
Somerset, NJ
5/1/2025Not yet inspected——No inspection yet
Imprimis NJOF, LLC
Ledgewood, NJ
11/12/20168/18/2026YesNoOpen
Molecular PharmaGroup
New Providence, NJ
5/8/20188/11/2025Yes (483)NoUntitled Letter Issued 2/5/2026
Quva Pharma, Inc.
Bloomsbury, NJ
9/15/20174/4/2025Yes (483)NoOpen
Sankav Pharmaceuticals, LLC
Hackettstown, NJ
3/21/2025Not yet inspected——No inspection yet
Stokes Healthcare Inc., dba Epicur Pharma
Mt. Laurel, NJ
1/30/20185/23/2025Yes (483)NoOpen

Compounding pharmacies in New Jersey that are not on this list

New Jersey's 503A pharmacies are licensed by the state board of pharmacy, not registered with the FDA, so they never appear here. Their record is the board's license lookup (NABP directory of boards). 503A vs 503B, explained.

Source: FDA — Registered Outsourcing Facilities, dated 2026-10-13. “Open” is an unfinalised classification, not a finding. Other states (16) · look up a pharmacy by name.

Before you sign

Is the pharmacy on your label in this table?

If it is, click through to its record. If it isn't, it is most likely a state-licensed 503A pharmacy; the board holds its license.

Free · independent reference · no account.

Three checks before you sign

  1. Find the pharmacy on the label. Compounded drugs name the pharmacy that made them, not the telehealth brand that sold them. That name is what you look up.

  2. Read the public record. Whether it is an FDA-registered 503B facility or a state-licensed 503A pharmacy, when it was last inspected, and what the FDA wrote down.

  3. Compare the approved path. What the FDA-approved version costs today next to the compounded one, and which licensed providers prescribe it — so the choice is yours, made on the record.

Independent and free — no account, nothing for sale.